iRhythm Technologies (NASDAQ:IRTC – Get Rating) had its price target boosted by research analysts at Truist Financial  from $137.00 to $154.00 in a research report issued on Monday, The Fly reports. The brokerage presently has a “buy” rating on the stock. Truist Financial’s price objective points to a potential upside of 16.76% from the company’s previous close.

Several other equities analysts have also commented on IRTC. Canaccord Genuity Group upped their price target on shares of iRhythm Technologies from $135.00 to $143.00 and gave the stock a “buy” rating in a research report on Friday, February 24th. BTIG Research upped their price objective on shares of iRhythm Technologies from $168.00 to $170.00 and gave the stock a “buy” rating in a report on Monday. Citigroup upped their price objective on shares of iRhythm Technologies from $110.00 to $130.00 and gave the stock a “neutral” rating in a report on Monday, April 3rd. Wells Fargo & Company began coverage on shares of iRhythm Technologies in a report on Tuesday, February 7th. They issued an “overweight” rating and a $150.00 price objective for the company. Finally, StockNews.com raised shares of iRhythm Technologies from a “sell” rating to a “hold” rating in a report on Wednesday, March 22nd. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, iRhythm Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $152.10.

iRhythm Technologies stock opened at $131.89 on Monday. The company has a 50-day simple moving average of $117.85 and a 200-day simple moving average of $110.12. The firm has a market capitalization of $4.02 billion, a P/E ratio of -33.90 and a beta of 1.42. The company has a debt-to-equity ratio of 0.15, a quick ratio of 3.07 and a current ratio of 3.24. iRhythm Technologies has a one year low of $85.74 and a one year high of $164.69.

iRhythm Technologies (NASDAQ:IRTC – Get Rating) last released its quarterly earnings results on Thursday, February 23rd. The company reported ($0.67) EPS for the quarter, missing the consensus estimate of ($0.63) by ($0.04). The firm had revenue of $112.62 million for the quarter, compared to the consensus estimate of $110.62 million. iRhythm Technologies had a negative return on equity of 35.85% and a negative net margin of 28.27%.  As a group, equities analysts expect that  iRhythm Technologies will post -2.82 earnings per share for the current year.

In other iRhythm Technologies news, EVP Daniel G. Wilson sold 1,726 shares of the business’s stock in a transaction dated Tuesday, February 28th. The stock was sold at an average price of $117.84, for a total transaction of $203,391.84. Following the sale, the executive vice president now owns 40,759 shares in the company, valued at approximately $4,803,040.56. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Daniel G. Wilson sold 1,726 shares of the company’s stock in a transaction dated Tuesday, February 28th. The stock was sold at an average price of $117.84, for a total value of $203,391.84. Following the transaction, the executive vice president now owns 40,759 shares in the company, valued at approximately $4,803,040.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Patrick Michael Murphy sold 571 shares of the stock in a transaction that occurred on Friday, March 3rd. The stock was sold at an average price of $117.23, for a total value of $66,938.33. Following the completion of the transaction, the executive vice president now owns 32,437 shares in the company, valued at approximately $3,802,589.51. The disclosure for this sale can be found here. In the last three months, insiders sold 15,317 shares of company stock valued at $1,831,058. 1.64% of the stock is owned by insiders.

Several hedge funds have recently modified their holdings of IRTC. Assenagon Asset Management S. A. bought a new position in  iRhythm Technologies in the first quarter worth $660,000.  Xponance Inc. acquired a new position in  iRhythm Technologies during the first quarter worth $218,000.  ETF Managers Group LLC acquired a new position in  iRhythm Technologies during the first quarter worth $92,000.  WoodTrust Financial Corp increased its stake in shares of  iRhythm Technologies by 12.3% in the first quarter. WoodTrust Financial Corp now owns 11,382 shares of the company’s stock valued at $1,412,000 after buying an additional 1,250 shares in the last quarter.  Finally, Raymond James & Associates increased its stake in shares of  iRhythm Technologies by 12.3% in the first quarter. Raymond James & Associates now owns 2,693 shares of the company’s stock valued at $334,000 after buying an additional 295 shares in the last quarter. 98.96% of the stock is owned by institutional investors.

iRhythm Technologies, Inc is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N.

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.